Trulieve Cannabis Corp. quarterly report, Q3 FY2025

Trulieve Cannabis Corp. 10-Q Summary: Q3 2025

Business Context and Reporting Period

This report covers the quarterly period ended September 30, 2025. Trulieve Cannabis Corp. is a vertically integrated multi-state cannabis operator with retail and cultivation facilities in nine U.S. states. As of the reporting date, the company operated 232 dispensaries and 15 cultivation/processing facilities. The company is a large accelerated filer and reports in U.S. dollars.

Key Financial Metrics

Metric Q3 2025 (3 Months) Q3 2024 (3 Months) YTD 2025 (9 Months) YTD 2024 (9 Months)
Revenue $288.2 million $284.3 million $888.0 million $885.3 million
Gross Profit $169.9 million $173.3 million $536.0 million $528.7 million
Gross Margin 58.9% 61.0% 60.4% 59.7%
Operating Income $42.2 million $0.6 million $128.2 million $96.5 million
Net Loss (GAAP) $(28.8) million $(61.9) million $(78.7) million $(99.0) million
Adjusted EBITDA $102.7 million $96.1 million $322.5 million $308.8 million
Cash & Equivalents $449.2 million $237.7 million $449.2 million $237.7 million
Operating Cash Flow (YTD) $213.6 million $240.8 million $213.6 million $240.8 million
Total Debt (Long-Term) $609.1 million $638.3 million $609.1 million $638.3 million

Note: Total Debt includes Private Placement Notes ($366.1M), Notes Payable ($107.7M), and Construction Finance Liabilities ($134.3M) as of Sept 30, 2025.

Material Changes vs. Prior Period

  • Revenue Growth: Q3 revenue increased 1.4% year-over-year, driven by new store openings, adult-use sales in Ohio, and wholesale growth, partially offset by price compression.
  • Expense Reduction: Selling, General, and Administrative (SG&A) expenses decreased significantly by 33% in Q3 ($99.0M vs $148.6M) and 10% YTD. This was primarily due to a reduction in campaign and political contributions ($6.3M in Q3 2025 vs $48.4M in Q3 2024).
  • Profitability: Operating income improved dramatically to $42.2M in Q3 2025 from $0.6M in Q3 2024. Net loss narrowed by 53% in Q3 and 21% YTD.
  • Liquidity: Cash and cash equivalents increased to $449.2M from $238.8M at year-end 2024, supported by strong operating cash flows.
  • Tax Liability: Uncertain tax position liabilities increased to $616.3M (from $445.2M at year-end 2024), driven by interest accruals on tax positions challenging IRC Section 280E.

Guidance, Outlook, and Risks

  • Subsequent Event: On November 4, 2025, the company issued a notice to redeem all outstanding $368.0 million of its 8% 2026 Notes on December 5, 2025.
  • Tax Contingencies: The IRS issued Revenue Agent Reports in September 2025 proposing assessments of taxes, interest, and penalties. While tax and interest amounts are accrued, a proposed penalty of approximately $38.1 million is not included in liabilities as the company intends to contest it vigorously.
  • Lease Guarantee: A $6.5 million liability was recorded in Q2 2025 due to a tenant default on a terminated cultivation lease where Trulieve is secondarily liable.
  • Outlook: Management expects existing cash balances to meet requirements for the next 12 months. The company continues to invest in infrastructure, technology, and market expansion, particularly in adult-use markets.
  • Risks: Key risks include federal illegality of cannabis, potential asset forfeiture, intense competition, and the outcome of ongoing IRS audits regarding IRC Section 280E.

Investor Verification Checklist

  • Debt Redemption: Verify the execution and funding of the $368M note redemption scheduled for December 5, 2025.
  • Tax Position: Monitor the status of the IRS audit and the $38.1M proposed penalty not currently accrued.
  • Price Compression: Assess the impact of ongoing price compression on gross margins in key markets like Florida and Arizona.
  • Political Contributions: Confirm the sustainability of reduced SG&A expenses given the historical volatility of campaign spending.
  • Lease Liability: Track the resolution of the $6.5M lease guarantee liability.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.